Oral vaccines: Directed safe passage to the front line of defense

Gut Microbes

Volumn 4, Issue 3, 2013, Pages

  Zhu, Qing ^a   Berzofsky, Jay A ^b  

^a INSTITUTE OF MATERIA MEDICA   (China)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Intestine; Mucosa; Nanoparticle; Oral vaccine; Rectogenital infection; T cell

Indexed keywords

ALPHA4 INTEGRIN; BETA1 INTEGRIN; CASPASE RECRUITMENT DOMAIN PROTEIN 15; CASPASE RECRUITMENT DOMAIN PROTEIN 4; CD8ALPHA ANTIGEN; CHEMOKINE RECEPTOR CCR9; CHEMOKINE RECEPTOR CXCR4; NANOPARTICLE; SECRETORY IMMUNOGLOBULIN; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 6; VACCINE;

ARTICLE; DEFENSE MECHANISM; DENDRITIC CELL; DRUG DELIVERY SYSTEM; HUMAN; IMMUNE RESPONSE; NONHUMAN; SMALL INTESTINE; VACCINATION;

EID: 84877321811     PISSN: 19490976     EISSN: 19490984     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Aylward B, Tangermann R. The global polio eradication initiative: lessons learned and prospects for success. Vaccine 2011; 29(Suppl 4):D80-5; PMID:22486981; http://dx.doi.org/10.1016/j.vaccine. 2011.10.005.
2. Ruiz-Palacios GM, Pérez-Schael I, Velázquez FR, Abate H, Breuer T, Clemens SC, et al.; Human Rotavirus Vaccine Study Group. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med 2006; 354:11-22; PMID:16394298; http://dx.doi.org/10.1056/ NEJMoa052434.
3. Vesikari T, Matson DO, Dennehy P, Van Damme P, Santosham M, Rodriguez Z, et al.; Rotavirus Efficacy and Safety Trial (REST) Study Team. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med 2006; 354:23-33; PMID:16394299; http://dx.doi. org/10.1056/NEJMoa052664.
4. Zhu Q, Thomson CW, Rosenthal KL, McDermott MR, Collins SM, Gauldie J. Immunization with adenovirus at the large intestinal mucosa as an effective vaccination strategy against sexually transmitted viral infection. Mucosal Immunol 2008; 1:78-88; PMID:19079163; http://dx.doi.org/10.1038/ mi.2007.3.
5. McConnell EL, Basit AW, Murdan S. Colonic antigen administration induces significantly higher humoral levels of colonic and vaginal IgA, and serum IgG compared to oral administration. Vaccine 2008; 26:639-46; PMID:18178292; http://dx.doi. org/10.1016/j.vaccine.2007.11.071.
6. Zhu Q, Egelston C, Vivekanandhan A, Uematsu S, Akira S, Klinman DM, et al. Toll-like receptor ligands synergize through distinct dendritic cell pathways to induce T cell responses: implications for vaccines. Proc Natl Acad Sci U S A 2008; 105:16260-5; PMID:18845682; http://dx.doi.org/10.1073/ pnas.0805325105.
7. Zhu Q, Egelston C, Gagnon S, Sui Y, Belyakov IM, Klinman DM, et al. Using 3 TLR ligands as a combination adjuvant induces qualitative changes in T cell responses needed for antiviral protection in mice. J Clin Invest 2010; 120:607-16; PMID:20101095; http://dx.doi.org/10.1172/JCI39293.
8. Nembrini C, Stano A, Dane KY, Ballester M, van der Vlies AJ, Marsland BJ, et al. Nanoparticle conjugation of antigen enhances cytotoxic T-cell responses in pulmonary vaccination. Proc Natl Acad Sci U S A 2011; 108:E989-97; PMID:21969597; http://dx.doi. org/10.1073/pnas.1104264108.
9. Desai MP, Labhasetwar V, Amidon GL, Levy RJ. Gastrointestinal uptake of biodegradable microparticles: effect of particle size. Pharm Res 1996; 13:1838-45; PMID:8987081; http://dx.doi. org/10.1023/A:1016085108889.
10. Lelouard H, Fallet M, de Bovis B, Méresse S, Gorvel JP. Peyer's patch dendritic cells sample antigens by extending dendrites through M cell-specific transcellular pores. Gastroenterology 2012; 142:592-601, e3; PMID:22155637; http://dx.doi.org/10.1053/j. gastro.2011.11.039.
11. Zhu Q, Talton J, Zhang G, Cunningham T, Wang Z, Waters RC, et al. Large intestine-targeted, nanoparticle-releasing oral vaccine to control genitorectal viral infection. Nat Med 2012; 18:1291-7; PMID:22797811; http://dx.doi.org/10.1038/ nm.2866.
12. Mestecky J, Russell MW. Specific antibody activity, glycan heterogeneity and polyreactivity contribute to the protective activity of S-IgA at mucosal surfaces. Immunol Lett 2009; 124:57-62; PMID:19524784; http://dx.doi.org/10.1016/j.imlet.2009.03.013.
13. Phalipon A, Cardona A, Kraehenbuhl JP, Edelman L, Sansonetti PJ, Corthésy B. Secretory component: a new role in secretory IgA-mediated immune exclusion in vivo. Immunity 2002; 17:107-15; PMID:12150896; http://dx.doi.org/10.1016/S1074-7613(02)00341-2.
14. Barington T, Kristensen K, Henrichsen J, Heilmann C. Influence of prevaccination immunity on the human B-lymphocyte response to a Haemophilus influenzae type b conjugate vaccine. Infect Immun 1991; 59:1057-64; PMID:1997409.
15. Serazin AC, Shackelton LA, Wilson C, Bhan MK. Improving the performance of enteric vaccines in the developing world. Nat Immunol 2010; 11:769-73; PMID:20720580; http://dx.doi.org/10.1038/ ni0910-769.
16. Hanley KA. The double-edged sword: How evolution can make or break a live-attenuated virus vaccine. Evolution (N Y) 2011; 4:635-43; PMID:22468165; http://dx.doi.org/10.1007/s12052-011-0365-y.
17. des Rieux A, Fievez V, Garinot M, Schneider YJ, Préat V. Nanoparticles as potential oral delivery systems of proteins and vaccines: a mechanistic approach. J Control Release 2006; 116:1-27; PMID:17050027; http://dx.doi.org/10.1016/j.jconrel.2006.08.013.
18. Cronkhite RI, Michael JG. Sub-compartmentalization of the gastrointestinal (GI) immune system determined with microbeads that differ in release properties. Vaccine 2004; 22:2106-15; PMID:15149766; http://dx.doi.org/10.1016/j.vaccine.2003.12.012.
19. Lange S, Holmgren J. Protective antitoxic cholera immunity in mice: influence of route and number of immunizations and mode of action of protective antibodies. Acta Pathol Microbiol Scand C 1978; 86C:145-52; PMID:696335; http://dx.doi. org/10.1111/j.1699-0463.1978.tb02572.x.
20. Snoeck V, Verfaillie T, Verdonck F, Goddeeris BM, Cox E. The jejunal Peyer's patches are the major inductive sites of the F4-specific immune response following intestinal immunisation of pigs with F4 (K88) fimbriae. Vaccine 2006; 24:3812-20; PMID:16099554; http://dx.doi.org/10.1016/j. vaccine.2005.07.025.
21. Belyakov IM, Hel Z, Kelsall B, Kuznetsov VA, Ahlers JD, Nacsa J, et al. Mucosal AIDS vaccine reduces disease and viral load in gut reservoir and blood after mucosal infection of macaques. Nat Med 2001; 7:1320-6; PMID:11726972; http://dx.doi. org/10.1038/nm1201-1320.
22. Belyakov IM, Isakov D, Zhu Q, Dzutsev A, Berzofsky JA. A novel functional CTL avidity/activity compartmentalization to the site of mucosal immunization contributes to protection of macaques against simian/ human immunodeficiency viral depletion of mucosal CD4+ T cells. J Immunol 2007; 178:7211-21; PMID:17513770.
23. Zhu Q, Thomson CW, Zhang G, Stämpfli M, McDermott MR, Collins SM, et al. Eosinophilia is induced in the colon of Th2-sensitized mice upon exposure to locally expressed antigen. Am J Physiol Gastrointest Liver Physiol 2007; 293:G383-90; PMID:17431215; http://dx.doi.org/10.1152/ ajpgi.00341.2006.
24. Stenstad H, Svensson M, Cucak H, Kotarsky K, Agace WW. Differential homing mechanisms regulate regionalized effector CD8alphabeta+ T cell accumulation within the small intestine. Proc Natl Acad Sci U S A 2007; 104:10122-7; PMID:17551016; http://dx.doi.org/10.1073/pnas.0700269104.
25. Wells JM, Rossi O, Meijerink M, van Baarlen P. Epithelial crosstalk at the microbiota-mucosal interface. Proc Natl Acad Sci U S A 2011; 108(Suppl 1):4607-14; PMID:20826446; http://dx.doi. org/10.1073/pnas.1000092107.
26. Lundqvist C, Baranov V, Hammarström S, Athlin L, Hammarström ML. Intra-epithelial lymphocytes. Evidence for regional specialization and extrathymic T cell maturation in the human gut epithelium. Int Immunol 1995; 7:1473-87; PMID:7495755; http:// dx.doi.org/10.1093/intimm/7.9.1473.
27. Suzuki H. Differences in intraepithelial lymphocytes in the proximal, middle, distal parts of small intestine, cecum, and colon of mice. Immunol Invest 2009; 38:780-96; PMID:19860588; http://dx.doi. org/10.3109/08820130903258800.
28. Fujiwara D, Chen L, Wei B, Braun J. Small intestine CD11c+ CD8+ T cells suppress CD4+ T cellinduced immune colitis. Am J Physiol Gastrointest Liver Physiol 2011; 300:G939-47; PMID:21436315; http://dx.doi.org/10.1152/ajpgi.00032.2010.
29. Wolff MJ, Leung JM, Davenport M, Poles MA, Cho I, Loke P. TH17, TH22 and Treg cells are enriched in the healthy human cecum. PLoS One 2012; 7:e41373; PMID:22829946; http://dx.doi. org/10.1371/journal.pone.0041373.
30. Kunkel EJ, Campbell JJ, Haraldsen G, Pan J, Boisvert J, Roberts AI, et al. Lymphocyte CC chemokine receptor 9 and epithelial thymus-expressed chemokine (TECK) expression distinguish the small intestinal immune compartment: Epithelial expression of tissue-specific chemokines as an organizing principle in regional immunity. J Exp Med 2000; 192:761-8; PMID:10974041; http://dx.doi. org/10.1084/jem.192.5.761.
31. Cassani B, Villablanca EJ, Quintana FJ, Love PE, Lacy-Hulbert A, Blaner WS, et al. Gut-tropic T cells that express integrin α4β7 and CCR9 are required for induction of oral immune tolerance in mice. Gastroenterology 2011; 141:2109-18; PMID:21925467; http://dx.doi.org/10.1053/j.gastro. 2011.09.015.
32. Connor SJ, Paraskevopoulos N, Newman R, Cuan N, Hampartzoumian T, Lloyd AR, et al. CCR2 expressing CD4+ T lymphocytes are preferentially recruited to the ileum in Crohn's disease. Gut 2004; 53:1287-94; PMID:15306587; http://dx.doi.org/10.1136/ gut.2003.028225.
33. Furrie E, Macfarlane S, Thomson G, Macfarlane GT; Microbiology & Gut Biology Group; Tayside Tissue & Tumour Bank. Toll-like receptors-2,-3 and-4 expression patterns on human colon and their regulation by mucosal-associated bacteria. Immunology 2005; 115:565-74; PMID:16011525; http://dx.doi. org/10.1111/j.1365-2567.2005.02200.x.
34. Ogura Y, Lala S, Xin W, Smith E, Dowds TA, Chen FF, et al. Expression of NOD2 in Paneth cells: a possible link to Crohn's ileitis. Gut 2003; 52:1591-7; PMID:14570728; http://dx.doi.org/10.1136/ gut.52.11.1591.
35. Geddes K, Rubino SJ, Magalhaes JG, Streutker C, Le Bourhis L, Cho JH, et al. Identification of an innate T helper type 17 response to intestinal bacterial pathogens. Nat Med 2011; 17:837-44; PMID:21666695; http://dx.doi.org/10.1038/nm.2391.
36. Schulte R, Kerneis S, Klinke S, Bartels H, Preger S, Kraehenbuhl JP, et al. Translocation of Yersinia entrocolitica across reconstituted intestinal epithelial monolayers is triggered by Yersinia invasin binding to beta1 integrins apically expressed on M-like cells. Cell Microbiol 2000; 2:173-85; PMID:11207574; http:// dx.doi.org/10.1046/j.1462-5822.2000.00047.x.
37. Baranov V, Hammarström S. Carcinoembryonic antigen (CEA) and CEA-related cell adhesion molecule 1 (CEACAM1), apically expressed on human colonic M cells, are potential receptors for microbial adhesion. Histochem Cell Biol 2004; 121:83-9; PMID:14758482; http://dx.doi.org/10.1007/ s00418-003-0613-5.
38. Dwinell MB, Eckmann L, Leopard JD, Varki NM, Kagnoff MF. Chemokine receptor expression by human intestinal epithelial cells. Gastroenterology 1999; 117:359-67; PMID:10419917; http://dx.doi. org/10.1053/gast.1999.0029900359.
39. Fotopoulos G, Harari A, Michetti P, Trono D, Pantaleo G, Kraehenbuhl JP. Transepithelial transport of HIV-1 by M cells is receptor-mediated. Proc Natl Acad Sci U S A 2002; 99:9410-4; PMID:12093918; http://dx.doi.org/10.1073/ pnas.142586899.
40. Yoshida M, Claypool SM, Wagner JS, Mizoguchi E, Mizoguchi A, Roopenian DC, et al. Human neonatal Fc receptor mediates transport of IgG into luminal secretions for delivery of antigens to mucosal dendritic cells. Immunity 2004; 20:769-83; PMID:15189741; http://dx.doi.org/10.1016/j. immuni.2004.05.007.
41. Hase K, Kawano K, Nochi T, Pontes GS, Fukuda S, Ebisawa M, et al. Uptake through glycoprotein 2 of FimH(+) bacteria by M cells initiates mucosal immune response. Nature 2009; 462:226-30; PMID:19907495; http://dx.doi.org/10.1038/ nature08529.
42. Tyrer PC, Ruth Foxwell A, Kyd JM, Otczyk DC, Cripps AW. Receptor mediated targeting of M-cells. Vaccine 2007; 25:3204-9; PMID:17276559; http:// dx.doi.org/10.1016/j.vaccine.2007.01.028.
43. Nochi T, Yuki Y, Matsumura A, Mejima M, Terahara K, Kim DY, et al. A novel M cell-specific carbohydrate-targeted mucosal vaccine effectively induces antigen-specific immune responses. J Exp Med 2007; 204:2789-96; PMID:17984304; http://dx.doi. org/10.1084/jem.20070607.
44. Devriendt B, De Geest BG, Goddeeris BM, Cox E. Crossing the barrier: Targeting epithelial receptors for enhanced oral vaccine delivery. J Control Release 2012; 160:431-9; PMID:22353618; http://dx.doi. org/10.1016/j.jconrel.2012.02.006.
45. Devriendt B, De Geest BG, Cox E. Designing oral vaccines targeting intestinal dendritic cells. Expert Opin Drug Deliv 2011; 8:467-83; PMID:21375470; http://dx.doi.org/10.1517/17425247.2011.561312.
46. Kraehenbuhl JP, Neutra MR. Epithelial M cells: differentiation and function. Annu Rev Cell Dev Biol 2000; 16:301-32; PMID:11031239; http://dx.doi. org/10.1146/annurev.cellbio.16.1.301.
47. Baker K, Qiao SW, Kuo T, Kobayashi K, Yoshida M, Lencer WI, et al. Immune and non-immune functions of the (not so) neonatal Fc receptor, FcRn. Semin Immunopathol 2009; 31:223-36; PMID:19495758; http://dx.doi.org/10.1007/s00281-009-0160-9.
48. Liu H, Komai-Koma M, Xu D, Liew FY. Toll-like receptor 2 signaling modulates the functions of CD4+ CD25+ regulatory T cells. Proc Natl Acad Sci U S A 2006; 103:7048-53; PMID:16632602; http:// dx.doi.org/10.1073/pnas.0601554103.
49. Zanin-Zhorov A, Cahalon L, Tal G, Margalit R, Lider O, Cohen IR. Heat shock protein 60 enhances CD4+ CD25+ regulatory T cell function via innate TLR2 signaling. J Clin Invest 2006; 116:2022-32; PMID:16767222; http://dx.doi.org/10.1172/ JCI28423.
50. Gibbons DL, Spencer J. Mouse and human intestinal immunity: same ballpark, different players; different rules, same score. Mucosal Immunol 2011; 4:148-57; PMID:21228770; http://dx.doi.org/10.1038/ mi.2010.85.